Abbott Labs gets FDA approval for diabetes device that doesn't require finger prick

​Abbott Laboratories secured clearance Wednesday to sell the first glucose monitor in the U.S. that does not require a routine finger prick.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.